HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sophie Chauvet Selected Research

Complement C3 Nephritic Factor

10/2022Results from a nationwide retrospective cohort measure the impact of C3 and soluble C5b-9 levels on kidney outcomes in C3 glomerulopathy.
6/2015Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sophie Chauvet Research Topics

Disease

5Atypical Hemolytic Uremic Syndrome
01/2022 - 04/2015
4Acute Kidney Injury (Acute Renal Failure)
01/2021 - 12/2014
4Proteinuria
01/2019 - 11/2011
4Paraproteinemias (Monoclonal Gammopathy)
01/2018 - 06/2015
3Albuminuria
02/2021 - 11/2011
3Chronic Renal Insufficiency
08/2020 - 12/2014
3Hemolysis
01/2020 - 01/2018
2Inflammation (Inflammations)
10/2022 - 01/2018
2Kidney Diseases (Kidney Disease)
07/2022 - 11/2015
2Sickle Cell Anemia (Hemoglobin S Disease)
01/2022 - 01/2018
2Glomerulonephritis
01/2020 - 11/2017
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2019 - 11/2015
2Lupus Nephritis
01/2019 - 10/2015
2Neoplasms (Cancer)
12/2014 - 11/2013
1Renal Insufficiency (Renal Failure)
10/2022
1Rare Diseases (Rare Disease)
10/2022
1Pre-Eclampsia (Preeclampsia)
01/2022
1Malignant Hypertension
01/2022
1Rhabdomyolysis
01/2021
1Necrosis
01/2020
1Vasculitis (Vasculitides)
01/2020
1Wounds and Injuries (Trauma)
01/2020
1Immunoglobulin Light-chain Amyloidosis
01/2019
1Pathologic Processes
01/2018
1Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
11/2017
1Infections
05/2017
1Hematuria
11/2015
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2015
1Kallmann Syndrome (Kallmann's Syndrome)
06/2015
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2014
1Edema (Dropsy)
12/2014
1Fibrosis (Cirrhosis)
01/2014
1Neoplasm Metastasis (Metastasis)
11/2013
1Breast Neoplasms (Breast Cancer)
11/2013

Drug/Important Bio-Agent (IBA)

11Complement System Proteins (Complement)IBA
10/2022 - 04/2015
6Immunoglobulins (Immunoglobulin)IBA
01/2020 - 01/2014
4Heme (Haem)IBA
01/2021 - 01/2018
4Immunoglobulin G (IgG)IBA
01/2020 - 01/2014
3AutoantibodiesIBA
01/2019 - 06/2015
2Complement C3 Nephritic FactorIBA
10/2022 - 06/2015
2Retinol-Binding Proteins (Retinoid Binding Proteins)IBA
02/2021 - 01/2014
2Complement C3 (C3 Complement)IBA
01/2021 - 04/2015
2Complement Factor H (Factor H)IBA
01/2020 - 06/2015
2phenylhydrazine (phenylhydrazine hydrochloride)IBA
01/2020 - 01/2018
2LigandsIBA
01/2018 - 11/2013
2Pharmaceutical PreparationsIBA
01/2018 - 12/2014
2Proteins (Proteins, Gene)FDA Link
11/2015 - 06/2015
2Semaphorins (Semaphorin)IBA
06/2015 - 11/2013
1Complement Membrane Attack Complex (Membrane Attack Complex)IBA
10/2022
1Biomarkers (Surrogate Marker)IBA
10/2022
1EnzymesIBA
01/2022
1HemopexinIBA
01/2021
1IfosfamideFDA LinkGeneric
08/2020
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2020
1Rituximab (Mabthera)FDA Link
01/2020
1Monoclonal AntibodiesIBA
01/2020
1Cisplatin (Platino)FDA LinkGeneric
01/2020
1Hemoglobins (Hemoglobin)IBA
01/2018
1Messenger RNA (mRNA)IBA
01/2018
1heme aIBA
01/2018
1Alternative Pathway Complement C3 ConvertaseIBA
11/2017
1Immunoglobulin M (IgM)IBA
11/2015
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
06/2015
1Folic Acid AntagonistsIBA
12/2014
1Pemetrexed (MTA)FDA Link
12/2014
1beta 2-Microglobulin (beta 2 Microglobulin)IBA
01/2014
1Transferrin (beta 2 Transferrin)IBA
01/2014
1plexinIBA
11/2013
1Endothelin Receptor AntagonistsIBA
11/2011
1Angiotensin Receptor AntagonistsIBA
11/2011
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
11/2011

Therapy/Procedure

1Therapeutics
07/2022
1Drug Therapy (Chemotherapy)
01/2020
1Remission Induction
01/2020
1Kidney Transplantation
12/2019